Ignacio Wistuba

33.9k citations
20 papers · 424 indexed · h-index 9
Topics
Cancer Immunotherapy and Biomarkers (4 papers)Cancer Research and Treatments (2 papers)Cervical Cancer and HPV Research (2 papers)

In The Last Decade

Ignacio Wistuba

19 papers receiving 415 citations

Peers

Ignacio Wistuba
Comparison fields: 5 of 59
  • Oncology 195
  • Molecular Biology 183
  • Pulmonary and Respiratory Medicine 147
  • Cancer Research 72
  • Immunology 60
Replace Maria Cardenas with:
Maria Cardenas United States
Jacqueline M. Liu Taiwan
Jae Myeong Lee South Korea
Marilisa Cargnelutti Italy
H.A. Burris United States
DC Betticher United Kingdom
Matteo Repetto Italy
John D. Miedler United States
E Patsouris Greece
Zuzana Kos Canada
Ignacio Wistuba relative to Maria Cardenas United States Maria Cardenas's profile →
Citations per field
00.5×2.8×
Maria Cardenas · 1×
Citations per year

Countries citing papers authored by Ignacio Wistuba

Since Specialization
Citations

This map shows the geographic impact of Ignacio Wistuba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Wistuba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Wistuba more than expected).

Fields of papers citing papers by Ignacio Wistuba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Wistuba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Wistuba. The network helps show where Ignacio Wistuba may publish in the future.

Co-authorship network of co-authors of Ignacio Wistuba

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio Wistuba. A scholar is included among the top collaborators of Ignacio Wistuba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio Wistuba. Ignacio Wistuba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 4
3 0
4 1
5 1
6 58
7 1
8 1
9 3
10 17
11 77
12 3
13 3
14 21
15 9
16 136
17 1
18 31
19 21
20 34

About Ignacio Wistuba

Ignacio Wistuba is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 20 papers that have together received 424 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Cancer Research and Treatments (2 papers) and Cervical Cancer and HPV Research (2 papers). The work is most often cited by research in Oncology (195 citations), Cancer Research (72 citations) and Pulmonary and Respiratory Medicine (147 citations). Ignacio Wistuba has collaborated with scholars based in United States, Chile and Romania. Frequent co-authors include Faye M. Johnson, Adi Gazdar, Naoko Takebe, Scott M. Lippman, George R. Blumenschein, Lei Feng, David J. Stewart, Jeremy J. Erasmus, Xi Tang and Hai T. Tran. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Nature Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026